These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 1617318

  • 1. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation.
    Labar B, Bogdanić V, Nemet D, Mrsić M, Vrtar M, Grgić-Markulin L, Kalenić S, Vujasinović S, Presecki V, Jakić-Razumović J.
    Bone Marrow Transplant; 1992 May; 9(5):343-7. PubMed ID: 1617318
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
    Fyles GM, Messner HA, Lockwood G, Curtis JE, Rider W, Minden MD, Meharchand JM, Lipton J, Tritchler D, Van Dyk J.
    Bone Marrow Transplant; 1991 Dec; 8(6):453-63. PubMed ID: 1790425
    [Abstract] [Full Text] [Related]

  • 3. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
    Belkacémi Y, Ozsahin M, Rio B, Laporte JP, Leblond V, Pène F, Laugier A.
    Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
    [Abstract] [Full Text] [Related]

  • 4. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Carlens S, Ringdén O, Aschan J, Hägglund H, Ljungman P, Mattsson J, Remberger M.
    Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation.
    Anderson JE, Appelbaum FR, Schoch G, Barnett T, Chauncey TR, Flowers ME, Storb R.
    Biol Blood Marrow Transplant; 2001 Apr; 7(3):163-70. PubMed ID: 11302550
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J.
    Bone Marrow Transplant; 1993 Apr; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [Abstract] [Full Text] [Related]

  • 8. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
    Hirabayashi N, Goto S, Ishii M, Yuge M, Mitsuma A, Noda N.
    Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
    [Abstract] [Full Text] [Related]

  • 9. Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.
    Kröger N, Zabelina T, Krüger W, Renges H, Stute N, Kabisch H, Jaburg N, Löliger C, Krüll A, Zander AR.
    Bone Marrow Transplant; 2001 Feb; 27(4):349-54. PubMed ID: 11313663
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities.
    Sutton L, Kuentz M, Cordonnier C, Blaise D, Devergie A, Guyotat D, Leblond V, Flesch M, Bordigoni P, Attal M.
    Bone Marrow Transplant; 1993 Dec; 12(6):583-9. PubMed ID: 8136742
    [Abstract] [Full Text] [Related]

  • 11. HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI.
    Willemze AJ, Geskus RB, Noordijk EM, Kal HB, Egeler RM, Vossen JM.
    Bone Marrow Transplant; 2007 Aug; 40(4):319-27. PubMed ID: 17572715
    [Abstract] [Full Text] [Related]

  • 12. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks.
    Igaki H, Karasawa K, Sakamaki H, Saito H, Nakagawa K, Ohtomo K, Tanaka Y.
    Strahlenther Onkol; 2005 Nov; 181(11):704-8. PubMed ID: 16254705
    [Abstract] [Full Text] [Related]

  • 13. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission.
    Helenglass G, Powles RL, McElwain TJ, Lakhani A, Milan S, Gore M, Nandi A, Zuiable A, Perren T, Forgeson G.
    Bone Marrow Transplant; 1988 Jan; 3(1):21-9. PubMed ID: 3048467
    [Abstract] [Full Text] [Related]

  • 14. Interstitial pneumonitis after allogeneic bone marrow transplantation following total body irradiation.
    Kurisu K, Taniguchi M, Kamikonya N, Hishikawa Y, Miura T, Inoue N, Kanamaru A, Kakishita E, Kai S, Hara H.
    Radiat Med; 1991 Jan; 9(3):118-21. PubMed ID: 1656487
    [Abstract] [Full Text] [Related]

  • 15. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M.
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Total body irradiation in bone marrow transplantation: fractionated vs single dose. Acute toxicity and preliminary results.
    Valls A, Grañena A, Carreras E, Ferrer E, Algara M.
    Bull Cancer; 1989 May; 76(8):797-804. PubMed ID: 2695178
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors affecting leukemia relapse after allogeneic BMT conditioned with cyclophosphamide and fractionated TBI.
    Zapatero A, Martín de Vidales C, Pinar B, Rodríguez F, Marín A, Cerezo L, Domínguez P, Pérez Torrubia A.
    Bone Marrow Transplant; 1996 Sep; 18(3):591-6. PubMed ID: 8879623
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G.
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [Abstract] [Full Text] [Related]

  • 20. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT, Krog C, Stockschläder M, Schleimer B, Zeller W, Krüger W, Erttmann R, Zander AR.
    Anticancer Res; 1997 Jun; 17(1B):589-99. PubMed ID: 9066585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.